<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
   xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
   xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
   xmlns="http://purl.org/rss/1.0/"
   xmlns:dc="http://purl.org/dc/elements/1.1/"
   xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
   xmlns:dcterms="http://purl.org/dc/terms/"

>
<channel rdf:about="http://www.citeulike.org/about">
<pubDate>Thu, 21 Aug 2008 15:11:27 BST</pubDate>


	<title>CiteULike: AlfonsoVicenteSuarez's il-10-general</title>
	<description>CiteULike: AlfonsoVicenteSuarez's il-10-general</description>


	<link>http://www.citeulike.org/user/AlfonsoVicenteSuarez/tag/il-10-general</link>
	<dc:publisher>CiteULike.org</dc:publisher>
	<dc:language>en-gb</dc:language>
	<dc:rights>Copyright &#169; 2004-2008 citeulike.org</dc:rights>
	<items>
    <rdf:Seq>
        <rdf:li rdf:resource="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1452726"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1452697"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1452644"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1452631"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1392505"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1392189"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1392182"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1390596"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1390588"/>

	</rdf:Seq>
	</items>
	</channel>


<item rdf:about="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1452726">
    <title>A Prominent Role for Sp1 During Lipopolysaccharide- Mediated Induction of the IL-10 Promoter in Macrophages -- Brightbill et al. 164 (4): 1940 -- The Journal of Immunology</title>
    <link>http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1452726</link>
    <description>&lt;i&gt;&lt;/i&gt;</description>
    <dc:title>A Prominent Role for Sp1 During Lipopolysaccharide- Mediated Induction of the IL-10 Promoter in Macrophages -- Brightbill et al. 164 (4): 1940 -- The Journal of Immunology</dc:title>

    <dc:date>2007-07-12T16:25:53-00:00</dc:date>
    <prism:category>il-10-general</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1452697">
    <title>Functional Analysis of -571 IL-10 Promoter Polymorphism Reveals a Repressor Element Controlled by Sp1 -- Steinke et al. 173 (5): 3215 -- The Journal of Immunology</title>
    <link>http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1452697</link>
    <description>&lt;i&gt;&lt;/i&gt;</description>
    <dc:title>Functional Analysis of -571 IL-10 Promoter Polymorphism Reveals a Repressor Element Controlled by Sp1 -- Steinke et al. 173 (5): 3215 -- The Journal of Immunology</dc:title>

    <dc:date>2007-07-12T16:02:19-00:00</dc:date>
    <prism:category>il-10-general</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1452644">
    <title>IL-10 Gene Expression Is Controlled by the Transcription Factors Sp1 and Sp3</title>
    <link>http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1452644</link>
    <description>&lt;i&gt;J Immunol, Vol. 165, No. 1. (1 July 2000), pp. 286-291.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;IL-10 is an 18-kDa cytokine with a key role in homeostatic control of inflammatory and immune responses. We have investigated how transcription of the IL-10 gene is regulated, so as to be able to understand the circumstances of IL-10 expression in both health and disease. In the mouse, IL-10 gene expression is regulated by a TATA-type promoter with a critical cis-acting element containing GGA repeats located at -89 to -77. Its complementary sequence is similar to the cis-acting elements (TCC repeats) in the promoters of genes encoding epidermal growth factor receptor and CD58. All these elements comprise a common CCTCCT sequence with less conserved C + T-rich sequences. Eliminating this CCTCCT sequence results in a marked reduction in promoter activity, suggesting a necessary role in IL-10 gene expression. Despite its dissimilarity to the G + C-rich Sp1 consensus sequence (GC box), Sp1 and Sp3 transcription factors could be shown to bind to this motif. The requirement for Sp1 and Sp3 in transcription of IL-10 was confirmed using Drosophila SL2 cells, which lack endogenous Sp factors. These results suggest that the transcription of IL-10 is positively regulated by both Sp1 and Sp3.</description>
    <dc:title>IL-10 Gene Expression Is Controlled by the Transcription Factors Sp1 and Sp3</dc:title>

    <dc:creator>Masahide Tone</dc:creator>
    <dc:creator>Mark Powell</dc:creator>
    <dc:creator>Yukiko Tone</dc:creator>
    <dc:creator>Sara Thompson</dc:creator>
    <dc:creator>Herman Waldmann</dc:creator>
    <dc:source>J Immunol, Vol. 165, No. 1. (1 July 2000), pp. 286-291.</dc:source>
    <dc:date>2007-07-12T15:33:49-00:00</dc:date>
    <prism:publicationYear>2000</prism:publicationYear>
    <prism:publicationName>J Immunol</prism:publicationName>
    <prism:volume>165</prism:volume>
    <prism:number>1</prism:number>
    <prism:startingPage>286</prism:startingPage>
    <prism:endingPage>291</prism:endingPage>
    <prism:category>il-10-general</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1452631">
    <title>Posttranscriptional Regulation of IL-10 Gene Expression Through Sequences in the 3'-Untranslated Region -- Powell et al. 165 (1): 292 -- The Journal of Immunology</title>
    <link>http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1452631</link>
    <description>&lt;i&gt;&lt;/i&gt;</description>
    <dc:title>Posttranscriptional Regulation of IL-10 Gene Expression Through Sequences in the 3'-Untranslated Region -- Powell et al. 165 (1): 292 -- The Journal of Immunology</dc:title>

    <dc:date>2007-07-12T15:27:32-00:00</dc:date>
    <prism:category>il-10-general</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1392505">
    <title>Identification of a Macrophage-Specific Chromatin Signature in the IL-10 Locus</title>
    <link>http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1392505</link>
    <description>&lt;i&gt;J Immunol, Vol. 175, No. 2. (15 July 2005), pp. 1041-1046.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;The molecular mechanisms that regulate expression of the immunosuppressive cytokine IL-10 remain poorly understood. In this study, by measuring sensitivity to DNase I digestion, we show that production of IL-10 by primary mouse bone marrow-derived macrophages stimulated through pattern recognition receptors was associated with chromatin remodeling of the IL-10 locus. We also demonstrate that the IL-10 locus is remodeled in primary Th2 cells and IL-10-producing regulatory T cells that have been differentiated in vitro. Strikingly, a novel DNase I-hypersensitive site (HSS-4.5) was identified in stimulated macrophages, but not in T cells. We show that hyperacetylated histones were recruited to this site in stimulated macrophages. Furthermore, HSS-4.5 is highly conserved and contains a putative NF-kappaB binding site. In support of a function for this site, NF-kappaB p65/RelA was recruited to HSS-4.5 in vivo and its activation was required for optimal IL-10 gene expression in LPS-stimulated macrophages.</description>
    <dc:title>Identification of a Macrophage-Specific Chromatin Signature in the IL-10 Locus</dc:title>

    <dc:creator>Margarida Saraivaparagraph</dc:creator>
    <dc:creator>Jillian Christensen</dc:creator>
    <dc:creator>Alla Tsytsykova</dc:creator>
    <dc:creator>Anne Goldfeld</dc:creator>
    <dc:creator>Steven Ley</dc:creator>
    <dc:creator>Dimitris Kioussis</dc:creator>
    <dc:creator>Anne O'Garra</dc:creator>
    <dc:source>J Immunol, Vol. 175, No. 2. (15 July 2005), pp. 1041-1046.</dc:source>
    <dc:date>2007-06-15T17:46:35-00:00</dc:date>
    <prism:publicationYear>2005</prism:publicationYear>
    <prism:publicationName>J Immunol</prism:publicationName>
    <prism:volume>175</prism:volume>
    <prism:number>2</prism:number>
    <prism:startingPage>1041</prism:startingPage>
    <prism:endingPage>1046</prism:endingPage>
    <prism:category>il-10-general</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1392189">
    <title>Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response</title>
    <link>http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1392189</link>
    <description>&lt;i&gt;Current Opinion in Pharmacology, Vol. 6, No. 4. (August 2006), pp. 379-386.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Interleukin (IL)-10 performs an irreplaceable role in negatively regulating inflammation, primarily through a mechanism that selectively blocks the expression of pro-inflammatory genes encoding cytokines, chemokines, cell-surface molecules and other molecules involved in the propagation of inflammation. Not surprisingly, IL-10 has attracted interest as a tool to regulate inflammatory diseases. The clinical use of IL-10 as an anti-inflammatory agent has, however, not met expectations. Nevertheless, the signaling pathway used by the IL-10 receptor to generate the anti-inflammatory response is only beginning to be understood and could be a way to regulate inflammation by pharmacological agents.</description>
    <dc:title>Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response</dc:title>

    <dc:creator>Peter Murray</dc:creator>
    <dc:source>Current Opinion in Pharmacology, Vol. 6, No. 4. (August 2006), pp. 379-386.</dc:source>
    <dc:date>2007-06-15T15:42:08-00:00</dc:date>
    <prism:publicationYear>2006</prism:publicationYear>
    <prism:publicationName>Current Opinion in Pharmacology</prism:publicationName>
    <prism:volume>6</prism:volume>
    <prism:number>4</prism:number>
    <prism:startingPage>379</prism:startingPage>
    <prism:endingPage>386</prism:endingPage>
    <prism:category>il-10-general</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1392182">
    <title>The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription</title>
    <link>http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1392182</link>
    <description>&lt;i&gt;PNAS, Vol. 102, No. 24. (14 June 2005), pp. 8686-8691.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;The antiinflammatory cytokine IL-10 inhibits the production of multiple, diverse inflammatory mediators from activated macrophages and dendritic cells, a process requiring STAT3 activation. However, the mechanisms involved in the broad inhibitory effects of IL-10 are controversial. I eliminated the contribution of the major confounding variable to understanding the antiinflammatory response, the 3' UTR region of inflammatory mediator genes, through knock-in mutation and analysis of the effects of IL-10 on transcription rate of inflammatory genes. IL-10 activates STAT3 to act indirectly by selectively inhibiting gene transcription independent of general effects on NF-kappaB or posttranscriptional mRNA processing through a process that reduces the overall transcriptional rate of specific genes. 10.1073/pnas.0500419102</description>
    <dc:title>The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription</dc:title>

    <dc:creator>Peter Murray</dc:creator>
    <dc:identifier>doi:10.1073/pnas.0500419102</dc:identifier>
    <dc:source>PNAS, Vol. 102, No. 24. (14 June 2005), pp. 8686-8691.</dc:source>
    <dc:date>2007-06-15T15:38:44-00:00</dc:date>
    <prism:publicationYear>2005</prism:publicationYear>
    <prism:publicationName>PNAS</prism:publicationName>
    <prism:volume>102</prism:volume>
    <prism:number>24</prism:number>
    <prism:startingPage>8686</prism:startingPage>
    <prism:endingPage>8691</prism:endingPage>
    <prism:category>il-10-general</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1390596">
    <title>INTERLEUKIN-10 AND THE INTERLEUKIN-10 RECEPTOR - Annual Review of Immunology, 19(1):683 - Abstract</title>
    <link>http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1390596</link>
    <description>&lt;i&gt;&lt;/i&gt;</description>
    <dc:title>INTERLEUKIN-10 AND THE INTERLEUKIN-10 RECEPTOR - Annual Review of Immunology, 19(1):683 - Abstract</dc:title>

    <dc:date>2007-06-14T19:57:21-00:00</dc:date>
    <prism:category>il-10-general</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1390588">
    <title>Interleukin-10 and Related Cytokines and Receptors - Annual Review of Immunology, 22(1):929 - Abstract</title>
    <link>http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1390588</link>
    <description>&lt;i&gt;&lt;/i&gt;</description>
    <dc:title>Interleukin-10 and Related Cytokines and Receptors - Annual Review of Immunology, 22(1):929 - Abstract</dc:title>

    <dc:date>2007-06-14T19:51:51-00:00</dc:date>
    <prism:category>il-10-general</prism:category>
</item>



</rdf:RDF>

